Long-term safety and efficacy of alogliptin, a DPP-4 inhibitor, in patients with type 2 diabetes: a 3-year prospective, controlled, observational study (J-BRAND Registry)
阿格列汀(一种 DPP-4 抑制剂)在 2 型糖尿病患者中的长期安全性和有效性:一项为期 3 年的前瞻性、对照、观察性研究(J-BRAND 注册研究)
期刊:Bmj Open Diabetes Research & Care
影响因子:4.1
doi:10.1136/bmjdrc-2020-001787
Ueki, Kohjiro; Tanizawa, Yukio; Nakamura, Jiro; Yamada, Yuichiro; Inagaki, Nobuya; Watada, Hirotaka; Shimomura, Iichiro; Nishimura, Rimei; Miyoshi, Hideaki; Abiko, Atsuko; Katagiri, Hideki; Hayashi, Michio; Shimada, Akira; Naruse, Keiko; Fujimoto, Shimpei; Fujiwara, Masazumi; Shikata, Kenichi; Okada, Yosuke; Araki, Eiichi; Yamazaki, Tsutomu; Kadowaki, Takashi